[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
[ Tue, Dec 06th 2022 ]: WOPRAI
Ashwani Verma Initiated (UTHR) at Strong Buy and Held Target at $320 on, Dec 6th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Ashwani Verma of UBS, Initiated "United Therapeutics Corporation" (UTHR) at Strong Buy and Held Target at $320 on, Dec 6th, 2022.
Ashwani has made no other calls on UTHR in the last 4 months.
There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Ashwani's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Ashwani
- Chris Shibutani of "Goldman Sachs" Initiated at Strong Sell and Held Target at $230 on, Monday, December 5th, 2022
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $375 on, Thursday, November 3rd, 2022
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $265 on, Thursday, November 3rd, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Thursday, November 3rd, 2022